Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Krystal Biotech, Inc.

Krystal Biotech, Inc. (KRYS) Stock Overview

Explore Krystal Biotech, Inc.’s financial performance, market position, analyst ratings, and future outlook.

KRYS●NASDAQ
HealthcareBiotechnology
$332.16
$13.66(3.95%)
U.S. Market is Open · 10:48

Krystal Biotech, Inc. (KRYS)

Meyka AI Score

Z

Key Financials

Market Cap9.9B
P/E Ratio41.14
EPS (TTM)$7.98
ROE0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$369.82
3 Months$407.14
1 Year Target$287.28

KRYS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Krystal Biotech, Inc. (NASDAQ: KRYS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Krystal Biotech, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of KRYS on the NASDAQ shows an RSI of 44.12, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $287.28 for the NASDAQ listing.

Key metrics behind Krystal Biotech, Inc.'s NASDAQ-traded stock include a P/E ratio of 41.14 and a market capitalization of 9.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of KRYS on the NASDAQ.

Price Performance (NASDAQ: KRYS)

1-Day Change
-2.53%
5-Day Change
-4.74%
1-Month Change
-4.09%
3-Month Change
-9.45%
6-Month Change
37.37%
Year-to-Date (YTD) Change
36.72%
1-Year Change
90.71%
3-Year Change
185.90%
5-Year Change
511.21%
All-Time (Max) Change
3068.05%

Contact Information

https://www.krystalbio.com
412 586 5830
2100 Wharton Street, Pittsburgh, PA, 15203

Company Facts

2,950 Employees
IPO DateSep 20, 2017
CountryUS
Actively Trading

Frequently Asked Questions